Diabetes and obesity - Issue 42/2021
Reviews
76
80
Compensation of social consequences of diabetes mellitus
Andrea Bukovská
86
News in the field of SGLT2 inhibitors
Zbynek Schroner
90
Diabetes and obesity
2021 Issue 42
Most read in this issue
- New possibility in therapy of diabetes mellitus: co-formulation of insulin degludec and insulin aspart
- Compensation of social consequences of diabetes mellitus
- News in the field of SGLT2 inhibitors
- Interesting (and not much discussed) aspects relevant for the choice of basal insulin